Stay updated with breaking news from Covaxin Eul. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Travellers vaccinated with Bharat Biotech's Covaxin can now enter US - Covaxin developed by Hyderabad-based Bharat Biotech in partnership with the Indian Council of Medical Research has a 78% efficacy rate against COVID.
The global body's Technical Advisory Group has determined that Covaxin meets WHO standards for protection against COVID-19, the benefit of the vaccine far outweighs risks and the vaccine can be used, WHO said.
Hyderabad-based Bharat Biotech, which has developed Covaxin, had submitted EOI (Expression of Interest) to the World Health Organisation on April 19
Bharat Biotech submitting Covaxin data 'regularly, very quickly': WHO heaps praise - Technical advisory group of World Health Organisation will reconvene on November 2 for final risk-benefit assessment of Bharat Biotech's Covaxin EUL.
Covaxin yet to get EUL, WHO seeks 'additional clarifications' from Bharat Biotech - The Covaxin jab has been approved in 14 countries and 70 million doses have been distributed overseas, Bharat Biotech told World Health Organisation.